Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore ...
The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...
Hernando County is coordinating efforts to control high levels of adult flying mosquitoes from the aftermath of Hurricane Milton. Aerial treatments are a large part of this response to provide ...